Entest Group, Inc. does not have significant operations. It intends to seek business opportunities to review and analyze for purposes of effecting a merger, acquisition, or other business combination with an operating company business. The company was formerly known as Entest Biomedical, Inc. and changed its name to Entest Group, Inc. in February 2018. Entest Group, Inc. was founded in 2008 and is...
Entest reported revenue of $0 for fiscal year 2019, and net income of $191,618. In Q1 2020 (the quarter ended November 30, 2019) revenue was $0. Its market capitalization was $9,834 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended August 31, 2019; market data as of October 9, 2026.
No profile data available.